Corteva, Inc. (CTVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Upgrading Corteva from Buy to Strong Buy due to macro conditions, including tariff-induced supply shocks, rising commodity prices, and currency tailwinds. Corteva's diversified supply chain and local production in seeds position it to benefit from regionalization and potential inflationary pressures in the agricultural sector. Strong Q4 earnings, record operating EBITDA margin, and robust free cash flow support the bullish outlook, with significant shareholder returns through dividends and buybacks.
Corteva, Dole, Adecoagro and Mission Produce have been highlighted in this Industry Outlook article.
This article explores a market inefficiency in fixed-income securities, specifically between Corteva's $4.50 and $3.50 Series Cumulative Preferred Stocks. We identified an arbitrage opportunity due to technical buying, making it an ideal pair trade with identical issues from the same company. On 02/09/2025, we recommended CTA-B for our investment-grade long-duration portfolio.
Goldman Sachs analyst Duffy Fischer initiated coverage on several major U.S. agriculture input stocks, citing several factors.
Corteva, Inc. (NYSE:CTVA ) Bank of America Global Agriculture & Materials Conference February 26, 2025 9:00 AM ET Company Participants Chuck Magro – Chief Executive Officer David Johnson – Executive Vice President, Chief Financial Officer Conference Call Participants Steve Byrne – Bank of America Securities Steve Byrne Welcome back. It's a pleasure for me to host this next session with Corteva.
Corteva, Inc. CTVA reported mixed fourth-quarter results, after the closing bell on Wednesday.
Corteva, Inc. (NYSE:CTVA ) Q4 2024 Earnings Conference Call February 6, 2024 9:00 AM ET Company Participants Kim Booth - VP, IR Chuck Magro - CEO David Johnson - EVP and CFO Judd O'Connor - EVP, Seed Business Unit Robert King - EVP, Crop Protection Unit Conference Call Participants Christopher Parkinson - Wolfe Research Vincent Andrews - Morgan Stanley Joel Jackson - BMO Capital Markets Kevin McCarthy - Vertical Research Josh Spector - UBS David Begleiter - Deutsche Bank Salvator Tiano - Bank of America Edlain Rodriguez - Mizuho Frank Mitsch - Fermium Research Richard Garchitorena - Wells Fargo Kristen Owen - Oppenheimer Arun Viswanathan - RBC Capital Markets Ben Theurer - Barclays Bank Operator Thank you for standing by. My name is Janine and I will be your lead operator for today's call.
Although the revenue and EPS for Corteva, Inc. (CTVA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Corteva, Inc. (CTVA) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.15 per share a year ago.
Evaluate the expected performance of Corteva, Inc. (CTVA) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Corteva, Inc. (CTVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.